SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CNSI Cambridge Neuroscience
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Peter R Smith who wrote ()3/8/2000 1:46:00 PM
From: scott_jiminez  Read Replies (1) of 675
 
I see CNSI as a $20-30 stock.

The consensus response to this will be, 'Your medication worn off again, Scott?'

I'll outline all my reasons soon but the underlying principle is that, in the current environment, it's patently absurd for CNSI to have a market cap of only $50 million. Fifty million!

This was precisely the stage I caught Ariad...where everyone was saying, 'But their pipeline is almost nonexistent' and I thought, 'Yes, but it's the potential of their platform that's gonna be the fireworks.'

The situation with CNSI is not directly analogous but the parallels in the 'unrecognized potential' category are striking. CNSI could easily support a market cap of $300-500 million.

And it was precisely at the time when everyone thought that Ariad was a basket case that I was buying. CNSI has significantly more potential than is recognized. Just watch.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News